Literature DB >> 4004766

Resealed red blood cells as a new blood transfusion product.

C Ropars, M Chassaigne, M C Villereal, G Avenard, C Hurel, C Nicolau.   

Abstract

Mesh：

Year:  1985        PMID： 4004766     DOI： 10.1159/000410231

Source DB:  PubMed          Journal:  Bibl Haematol        ISSN： 0067-7957


× No keyword cloud information.
  9 in total

1.  Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.

Authors:  C L Mintzer; P Deloron; A Rice-Ficht; D Durica; D K Struck; C A Roessner; C Nicolau; G M Ihler
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Erythrocytes as carriers for recombinant human erythropoietin.

Authors:  M I Garín; R M López; S Sanz; M Pinilla; J Luque
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

3.  Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.

Authors:  A De Flora; E Zocchi; L Guida; C Polvani; U Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 4.  Carrier erythrocytes. Clinical pharmacokinetic considerations.

Authors:  M Tonetti; A De Flora
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

5.  Engineered erythrocytes: influence of P50 rightward shift and oxemia on oxygen transport to tissues.

Authors:  C Ropars; M Chassaigne; G Avenard
Journal:  Med Biol Eng Comput       Date:  1998-07       Impact factor: 2.602

6.  Improved pharmacodynamics of L-asparaginase-loaded in human red blood cells.

Authors:  R Kravtzoff; I Desbois; J P Lamagnere; J P Muh; C Valat; M Chassaigne; P Colombat; C Ropars
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

7.  Encapsulation of adriamycin in human erythrocytes.

Authors:  A De Flora; U Benatti; L Guida; E Zocchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Phorbol 12-myristate 13-acetate-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M.

Authors:  Z Al; C M Cohen
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

9.  A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients.

Authors:  V Lucidi; A E Tozzi; S Bella; A Turchetta
Journal:  BMC Pediatr       Date:  2006-05-24       Impact factor: 2.125
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.